REVTECH INDUSTRIES

Artemis AI is the world's first intelligent multi-sensor connected mental health device developed by REVTECH INDUSTRIES. It combines advanced biometric monitoring, real-time AI analysis, and personalized therapy delivery to provide comprehensive mental health support. The system operates with 15+ integrated sensors and uses proprietary AI algorithms to detect mood patterns with 99.7% accuracy.

Artemis AI uses advanced machine learning algorithms that process over 50,000 data points from biometric sensors, voice patterns, and behavioral indicators. The AI learns from each interaction, adapting to individual user patterns and preferences. All processing happens locally on the device, ensuring complete privacy while providing increasingly personalized responses over time.

Currently, Artemis AI beta applications are available for Android (Universal and Legacy APKs) and Windows (ZIP installation). The Android version includes the new Live Voice Call feature. macOS and iOS versions are in development and coming soon. All versions operate completely offline after initial download.

Yes, privacy is our core principle. All AI processing happens locally on your device - no data is transmitted to external servers. Your conversations, biometric data, and personal information never leave your device. The application uses advanced encryption for local storage and includes PIN authentication and biometric security features for enhanced protection.

The Artemis AI device integrates 15+ sensors including microphones for voice analysis, microwave sensors for movement detection, IR sensors for thermal monitoring, and various biometric sensors. The system architecture uses a modular cylindrical design that allows for sensor upgrades and customization. Detailed blueprints and specifications are available in our portfolio section.

Yes, the beta applications are free to download for testing and development purposes. However, please note these are experimental builds and may contain bugs or incomplete features. Use at your own risk. The applications are protected and obfuscated for security, and include advanced features like offline AI learning and voice call capabilities.

We welcome partnerships, licensing opportunities, research collaborations, and investment inquiries. Please use the contact form on this website or email us directly at revtech.industries@outlook.com. We're particularly interested in healthcare partnerships, technology licensing, and research collaborations that can help bring Artemis AI to more users.

Phase 1 (2022-2025) is complete, covering foundation and prototyping. We're currently in Year 1 (2026) of our 4-year roadmap, focusing on beta launch and market entry. Year 2 (2027) will focus on scale and growth with 10,000+ users and enterprise solutions. Year 3 (2028) targets market leadership with 100,000+ users and FDA pathway progress. Year 4 (2029) aims for industry transformation with 500,000+ users and FDA approval. See our Roadmap section for detailed quarterly milestones across all 4 years.

All Artemis AI technology, designs, software, and hardware specifications are copyrighted and proprietary to REVTECH INDUSTRIES. We have provisional patent applications filed for core technologies, and all trademarks for "Artemis AI" and "REVTECH INDUSTRIES" are protected. For licensing inquiries, please contact us through the contact form or email.

The Live Voice Call feature allows you to have real-time voice conversations with Artemis AI. You can speak naturally, and Artemis responds with intelligent, empathetic responses powered by offline learning AI. The feature includes automatic feedback prevention, intelligent timing, and personalized responses. It's currently available in the Android beta version and works completely offline.